These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 17936507)

  • 1. Oxygen carriers and cancer chemo- and radiotherapy sensitization: bench to bedside and back.
    Yu M; Dai M; Liu Q; Xiu R
    Cancer Treat Rev; 2007 Dec; 33(8):757-61. PubMed ID: 17936507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Red cell substitutes.
    Winslow RM
    Semin Hematol; 2007 Jan; 44(1):51-9. PubMed ID: 17198847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Radiosensitizing effects of perfluorochemicals].
    Hasegawa T; Harima K; Tanaka Y
    Gan No Rinsho; 1988 Oct; 34(13):1864-8. PubMed ID: 3143842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxygen carriers.
    Chang TM
    Curr Opin Investig Drugs; 2002 Aug; 3(8):1187-90. PubMed ID: 12211412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The development of hemoglobin solutions as red cell substitutes.
    Ogden JE; Parry ES
    Int Anesthesiol Clin; 1995; 33(1):115-29. PubMed ID: 7635553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Artificial oxygen carriers as red blood cell substitutes: a selected review and current status.
    Kim HW; Greenburg AG
    Artif Organs; 2004 Sep; 28(9):813-28. PubMed ID: 15320945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Artificial oxygen carriers. Alternatives to homologous blood transfusion?].
    Habler O; Kleen M; Messmer K
    Zentralbl Chir; 1999; 124(4):260-70. PubMed ID: 10355079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternative oxygen therapeutics: products, status of clinical trials, and future prospects.
    Winslow RM
    Curr Hematol Rep; 2003 Nov; 2(6):503-10. PubMed ID: 14561395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toward 21st century blood component replacement therapeutics: artificial oxygen carriers, platelet substitutes, recombinant clotting factors, and others.
    Kim HW; Greenburg AG
    Artif Cells Blood Substit Immobil Biotechnol; 2006; 34(6):537-50. PubMed ID: 17090427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Artificial oxygen carriers: a current review.
    Henkel-Honke T; Oleck M
    AANA J; 2007 Jun; 75(3):205-11. PubMed ID: 17591302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current aspects in red blood cell substitutes].
    Wang Y; Pan J; Yu Y
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Jun; 21(3):490-4. PubMed ID: 15250164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of artificial cells using nanobiotechnology of hemoglobin based RBC blood substitute as an example.
    Chang TM
    Artif Cells Blood Substit Immobil Biotechnol; 2006; 34(6):551-66. PubMed ID: 17090428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perfluorinated blood substitutes and artificial oxygen carriers.
    Lowe KC
    Blood Rev; 1999 Sep; 13(3):171-84. PubMed ID: 10527269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anemia and radiotherapy].
    Pasquier D; Lartigau E
    Bull Cancer; 2003 Apr; 90 Spec No():S152-7. PubMed ID: 12856427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The status of hemoglobin-based red cell substitutes.
    Rabinovici R
    Isr Med Assoc J; 2001 Sep; 3(9):691-7. PubMed ID: 11574989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liposome-Encapsulated Hemoglobin, TRM-645: Current Status of the Development and Important Issues for Clinical Application.
    Kaneda S; Ishizuka T; Goto H; Kimura T; Inaba K; Kasukawa H
    Artif Organs; 2009 Feb; 33(2):146-52. PubMed ID: 19178459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiation sensitization with redox modulators: a promising approach.
    Rosenberg A; Knox S
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):343-54. PubMed ID: 16414370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxic tumor cell radiosensitization: role of the iNOS/NO pathway.
    De Ridder M; Van Esch G; Engels B; Verovski V; Storme G
    Bull Cancer; 2008 Mar; 95(3):282-91. PubMed ID: 18390408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current status of oxygen carriers ('blood substitutes'): 2006.
    Winslow RM
    Vox Sang; 2006 Aug; 91(2):102-10. PubMed ID: 16907870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemoglobin-based oxygen carrier enhanced tumor oxygenation: a novel strategy for cancer therapy.
    Gundersen SI; Palmer AF
    Biotechnol Prog; 2008; 24(6):1353-64. PubMed ID: 19194950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.